Work

Human vaccines & immunotherapeutics: News August 2022

Year: 2022

Type: editorial

Abstract: The US Food and Drug Administration (FDA) has expanded the emergency-use authorization of the two mRNA Covid-19 vaccines to include a booster dose of bivalent formulations ≥2 months after the prima...

Source: Human Vaccines & Immunotherapeutics

DOI: 10.1080/21645515.2022.2123687

Authors: Ronald Ellis, Adam Weiss

Institution: Taylor and Francis (United Kingdom)

Language: English

Topic: SARS-CoV-2 and COVID-19 Research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,175

OpenAlex ID: W4296458226

Cites: 3

Cited by:

Related to: 10